Efg Capital International Corp. Biomarin Pharmaceutical Inc Transaction History
Efg Capital International Corp.
- $432 Billion
- Q2 2023
A detailed history of Efg Capital International Corp. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Efg Capital International Corp. holds 16,602 shares of BMRN stock, worth $1.4 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
16,602Holding current value
$1.4 Million% of portfolio
0.33%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
621Shares Held
182MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.58 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.53 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.22 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.18 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$583 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.7B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...